1. |
Lee HY, Oh BH. Heart transplantation in Asia. Circ J, 2017, 81(5): 617-621.
|
2. |
Hess NR, Ziegler LA, Kaczorowski DJ. Heart donation and preservation: Historical perspectives, current technologies, and future directions. J Clin Med, 2022, 11(19): 5762.
|
3. |
Qin G, Su Y, Sjöberg T, et al. Oxygen consumption of the aerobically-perfused cardioplegic donor heart at different temperatures. Ann Transplant, 2018, 23: 268-273.
|
4. |
李建辉, 徐骁, 谢海洋, 等. 中国移植器官保护专家共识 (2022版). 器官移植, 2022, 13(2): 144-160.Li JH, Xu X, Xie HY, et al. Chinese expert consensus on organ protection of transplantation (2022 edition). Organ Transpl, 2022, 13(2): 144-160.
|
5. |
Van Caenegem O, Beauloye C, Bertrand L, et al. Hypothermic continuous machine perfusion enables preservation of energy charge and functional recovery of heart grafts in an ex vivo model of donation following circulatory death. Eur J Cardiothorac Surg, 2016, 49(5): 1348-1353.
|
6. |
Ragalie WS, Ardehali A. Current status of normothermic ex-vivo perfusion of cardiac allografts. Curr Opin Organ Transplant, 2020, 25(3): 237-240.
|
7. |
李勇男. 不同心脏保存液对供体心脏保护效果评价与供体心脏中冷诱导RNA结合蛋白作用机制的研究. 兰州大学, 2019.Li YN. Compared efficacy of preservation solutions on the outcome of heart transplantation and effects of cold-inducible RNA-binding protein in the cold stored hearts. Lanzhou University, 2019.
|
8. |
Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report-2013; Focus theme: Age. J Heart Lung Transplant, 2013, 32(10): 951-964.
|
9. |
孙永丰, 董念国, 刘金平, 等. 供心冷缺血时间对临床心脏移植近中期疗效的影响分析. 中华器官移植杂志, 2014, 35(6): 329-332.Sun YF, Dong NG, Liu JP, et al. Effect of ischemic time on survival after heart transplantation. Chin J Organ Transplant, 2014, 35(6): 329-332.
|
10. |
Wyss RK, Méndez-Carmona N, Sanz MN, et al. Mitochondrial integrity during early reperfusion in an isolated rat heart model of donation after circulatory death-consequences of ischemic duration. J Heart Lung Transplant, 2019, 38(6): 647-657.
|
11. |
Ribeiro R, Ghashghai A, Yu F, et al, Comparison between Steen and Somah solutions as primary perfusate components for ex vivo heart perfusion. Canadian J Cardiol, 2017, 33(10): S69.
|
12. |
Hu CX, Chen WH, He JX, et al. Lung transplantation in China between 2015 and 2018. Chin Med J (Engl), 2019, 132(23): 2783-2789.
|
13. |
Chocron S, Kaili D, Yan Y, et al. Intermediate lukewarm (20 degrees c) antegrade intermittent blood cardioplegia compared with cold and warm blood cardioplegia. J Thorac Cardiovasc Surg, 2000, 119(3): 610-616.
|
14. |
Buckberg GD. Oxygenated cardioplegia: Blood is a many splendored thing. Ann Thorac Surg, 1990, 50(2): 175-177.
|
15. |
Minatoya K, Okabayashi H, Shimada I, et al. Intermittent antegrade warm blood cardioplegia for CABG: Extended interval of cardioplegia. Ann Thorac Surg, 2000, 69(1): 74-76.
|
16. |
马啸龙, 陈博, 刘成, 等. 体外膜肺氧合中血栓炎症反应及管路生物相容性的研究进展. 临床检验杂志, 2023, 41(6): 444-448.Ma XL, Chen B, Liu C, et al. Progress in the study of thrombo-inflammatory response and pipeline biocompatibility in extracorporeal membrane oxygenation. Chin J Clin Lab Sci, 2023, 41(6): 444-448.
|
17. |
周玉阳. 低温含血Plegisol液微流量持续灌注对热缺血猪心的保护作用. 郑州大学, 2011.Zhou YY. The myocardial protection effect of micro-flow perfusionwith hypothermic bloody plegisol solution on warm ischemic pig heart graft. Zhengzhou University, 2011.
|
18. |
Miles JA, Quispe R, Mehlman Y, et al. Racial differences and mortality risk in patients with heart failure and hyponatremia. PLoS One, 2019, 14(6): e0218504.
|
19. |
Kinugawa K, Sato N, Inomata T, et al. Novel risk score efficiently prevents tolvaptan-induced hypernatremic events in patients with heart failure. Circ J, 2018, 82(5): 1344-1350.
|
20. |
向采霏, 姜文凯, 郎泽昆, 等. 心脏体外循环术后高钠血症的原因探讨. 心血管病学进展, 2021, 42(12): 1089-1092.Xiang CF, Jiang WK, Lang ZK, et al. The cause of hypernatremia after cardiopulmonary bypass. Adv Cardiovasc Dis, 2021, 42(12): 1089-1092.
|
21. |
Ying WZ, Aaron K, Wang PX, et al. Potassium inhibits dietary salt-induced transforming growth factor-beta production. Hypertension, 2009, 54(5): 1159-1163.
|
22. |
Lorenz JN, Loreaux EL, Dostanic-Larson I, et al. ACTH-induced hypertension is dependent on the ouabain-binding site of the alpha2-Na+-K+-ATPase subunit. Am J Physiol Heart Circ Physiol, 2008, 295(1): H273-H280.
|
23. |
Hunter RW, Bailey MA. Hyperkalemia: Pathophysiology, risk factors and consequences. Nephrol Dial Transplant, 2019, 34(Suppl 3): iii2-iii11.
|
24. |
Válek M, Roblová L, Raška I, et al. Hypocalcaemic cardiomyopathy: A description of two cases and a literature review. ESC Heart Fail, 2020, 7(3): 1291-1301.
|
25. |
Chrysant SG. Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias. Expert Rev Cardiovasc Ther, 2019, 17(5): 345-351.
|
26. |
侯安存. 儿童心肌损伤检测指标的研究进展及优选劣汰. 临床和实验医学杂志, 2015, 14(20): 1750-1753.Hou AC. Research progress and optimal selection of indicators for cardiac myocardial injury detection in children. J Clin Exp Med, 2015, 14(20): 1750-1753.
|
27. |
卢美娜, 华春珍, 贾艳会. 病毒性心肌炎患儿外周血心肌酶谱指标变化及与预后的关系. 中国妇幼保健, 2022, 37(6): 1018-1021.Lu MN, Hua CZ, Jia YH. Changes in peripheral blood cardiomyocyte enzyme spectrum indicators in children with viral myocarditis and their relationship with prognosis. Matern Child Health Care China, 2022, 37(6): 1018-1021.
|
28. |
肖文, 胡长新, 周士娣. 有机磷中毒早期心肌损伤患者血清NT-proBNP、IL-18、α-HBDH水平变化及临床意义. 牡丹江医学院学报, 2024, 45(1): 47-50, 63.Xiao W, Hu CX, Zhou SD. Changes in serum NT-proBNP, IL-18, and α-HBDH levels and clinical significance in patients with early myocardial injury due to organic phosphorus poisoning. J Mudanjiang Med Univ, 2024, 45(1): 47-50, 63.
|